share_log

Canaccord Genuity Maintains Buy on 2seventy Bio, Lowers Price Target to $11

Benzinga ·  May 9 15:08

Canaccord Genuity analyst John Newman maintains 2seventy bio (NASDAQ:TSVT) with a Buy and lowers the price target from $12 to $11.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment